Analyst Ratings For NASDAQ:ASLN – ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ:ASLN)
Today, Leerink Swann initiated coverage on NASDAQ:ASLN – ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ:ASLN) with a Market Perform.
Some recent analyst ratings include
- 5/30/2018-Leerink Swann initiated coverage with a Market Perform rating.
- 5/30/2018-BTIG Research initiated coverage with a Buy rating.
- 5/30/2018-HC Wainwright initiated coverage with a Buy rating.
- 5/30/2018-Piper Jaffray Companies initiated coverage with a Overweight rating.
Recent Trading Activity for NASDAQ:ASLN – ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ:ASLN)
Shares of NASDAQ:ASLN – ASLAN PHARMACEUTICALS ADR REP 5 closed the previous trading session at 7.32 up +0.47 6.86% with 6.989999771118164 shares trading hands.